NO20005418L - Homogene farmasöytiske sammensetninger omfattende abacavir, lamivudin og zidovudin - Google Patents

Homogene farmasöytiske sammensetninger omfattende abacavir, lamivudin og zidovudin

Info

Publication number
NO20005418L
NO20005418L NO20005418A NO20005418A NO20005418L NO 20005418 L NO20005418 L NO 20005418L NO 20005418 A NO20005418 A NO 20005418A NO 20005418 A NO20005418 A NO 20005418A NO 20005418 L NO20005418 L NO 20005418L
Authority
NO
Norway
Prior art keywords
abacavir
lamivudine
zidovudine
pharmaceutical compositions
homogeneous pharmaceutical
Prior art date
Application number
NO20005418A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005418D0 (no
Inventor
Robin Currie
Sunil Jain
Allen Wayne Wood
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20005418D0 publication Critical patent/NO20005418D0/no
Publication of NO20005418L publication Critical patent/NO20005418L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20005418A 1998-04-29 2000-10-27 Homogene farmasöytiske sammensetninger omfattende abacavir, lamivudin og zidovudin NO20005418L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809213.3A GB9809213D0 (en) 1998-04-29 1998-04-29 Pharmaceutical compositions
PCT/EP1999/002794 WO1999055372A1 (en) 1998-04-29 1999-04-26 Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine

Publications (2)

Publication Number Publication Date
NO20005418D0 NO20005418D0 (no) 2000-10-27
NO20005418L true NO20005418L (no) 2000-11-29

Family

ID=10831228

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005418A NO20005418L (no) 1998-04-29 2000-10-27 Homogene farmasöytiske sammensetninger omfattende abacavir, lamivudin og zidovudin

Country Status (23)

Country Link
EP (1) EP1083932A1 (id)
JP (1) JP2002512979A (id)
KR (1) KR20010043128A (id)
CN (1) CN1411380A (id)
AP (1) AP2000001971A0 (id)
AU (1) AU4135599A (id)
BR (1) BR9910071A (id)
CA (1) CA2330391A1 (id)
EA (1) EA200000997A1 (id)
EE (1) EE200000646A (id)
GB (1) GB9809213D0 (id)
HR (1) HRP20000732A2 (id)
HU (1) HUP0101622A3 (id)
ID (1) ID26955A (id)
IL (1) IL139181A0 (id)
IS (1) IS5675A (id)
NO (1) NO20005418L (id)
NZ (1) NZ507745A (id)
PL (1) PL343710A1 (id)
SK (1) SK16212000A3 (id)
TR (1) TR200003157T2 (id)
WO (1) WO1999055372A1 (id)
ZA (1) ZA200005922B (id)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4219799A (en) * 1998-05-29 1999-12-13 University Of Florida Combination therapy for treatment of fiv infection
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AU2002311622A1 (en) * 2002-04-23 2003-11-10 Lupin Limited Long acting compositions comprising zidovudine and lamivudine
TW200403061A (en) * 2002-06-04 2004-03-01 Glaxo Group Ltd Pharmaceutical compositions
CN100335125C (zh) * 2003-06-03 2007-09-05 上海现代药物制剂工程研究中心 杀毒抗菌用长效干扰素喷鼻粉剂
WO2006114709A1 (en) * 2005-04-25 2006-11-02 Aurobindo Pharma Limited Pharmaceutical compositions of antiretrovirals
US20070059360A1 (en) * 2005-07-29 2007-03-15 Ashish Jaiswal Water-dispersible anti-retroviral pharmaceutical compositions
ES2279707B1 (es) * 2005-11-10 2008-06-01 Combino Pharm, S.L. Formulaciones orales que comprenden 3'-azidonucleosidos.
US20110053884A1 (en) * 2007-10-02 2011-03-03 Schinazi Raymond F Potent combinations of zidovudine and drugs that select for the k65r mutation in the hiv polymerase
US20110117193A1 (en) * 2008-01-17 2011-05-19 Duquesne University Of The Holy Spirit Antiretroviral drug formulations for treatment of children exposed to hiv/aids
EP3351249A1 (en) * 2010-01-27 2018-07-25 VIIV Healthcare Company Antiviral therapy
CN114010776A (zh) 2010-06-09 2022-02-08 疫苗技术股份有限公司 用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
CA2866133A1 (en) 2012-03-05 2013-09-12 Cipla Limited Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine
EP2911674A1 (en) 2012-10-23 2015-09-02 Cipla Limited Pharmaceutical antiretroviral composition
HUE066123T2 (hu) * 2013-06-13 2024-07-28 Akebia Therapeutics Inc Készítmények és módszerek anémia kezelésére
CN117618453A (zh) * 2022-08-24 2024-03-01 安徽贝克制药股份有限公司 包含阿巴卡韦、齐多夫定和拉米夫定的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
JP2002512979A (ja) 2002-05-08
EE200000646A (et) 2002-04-15
HUP0101622A2 (hu) 2002-03-28
WO1999055372A1 (en) 1999-11-04
HRP20000732A2 (en) 2001-02-28
EA200000997A1 (ru) 2001-06-25
GB9809213D0 (en) 1998-07-01
AU4135599A (en) 1999-11-16
PL343710A1 (en) 2001-08-27
HUP0101622A3 (en) 2003-09-29
SK16212000A3 (sk) 2001-07-10
IL139181A0 (en) 2001-11-25
EP1083932A1 (en) 2001-03-21
ID26955A (id) 2001-02-22
KR20010043128A (ko) 2001-05-25
BR9910071A (pt) 2000-12-26
NO20005418D0 (no) 2000-10-27
IS5675A (is) 2000-10-20
TR200003157T2 (tr) 2001-01-22
CN1411380A (zh) 2003-04-16
ZA200005922B (en) 2001-10-23
CA2330391A1 (en) 1999-11-04
NZ507745A (en) 2004-07-30
AP2000001971A0 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
NO20005418D0 (no) Homogene farmasøytiske sammensetninger omfattende abacavir, lamivudin og zidovudin
DK1095016T3 (da) Svovlsubstituerede sulfonylaminocarboxylsyre-N-arylamider, deres fremstilling, deres anvendelse og farmaceutiske præparater omfattende dem
IS5046A (is) Lyfjasamsetningar
DE69907162D1 (de) Organophile phyllosilikate
ITMI991478A1 (it) Composizione pesticida che contiene emamectin
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
NO20024355L (no) Nukleosidforbindelser og anvendelser derav
ID26549A (id) Komposisi-komposisi epotilon
ATE367793T1 (de) Schweisshemmende zusammensetzungen
DK1112266T3 (da) Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
NO20006520L (no) Adenosinderivater
ATE469550T1 (de) Antiparasitäre zusammensetzungen
EP0994183A4 (en) FUNCTIONAL COMPOSITIONS
ID29262A (id) Komposisi farmasi
DE69927758D1 (de) Imidosilan-Zusammensetzungen
NO20004160D0 (no) Langrenns- eller turskibinding
IS5827A (is) Múskarín gerandefni og mótlyf
IS6677A (is) Amínóalkýlbensóýl-bensófúran eða bensóþíófenafleiður, aðferð til framleiðslu þeirra og samsetningarsem innihalda þær
ID27889A (id) Komposisi-komposisi kopolimer polisiklik
ID22405A (id) Komposisi pestisida
IS5024A (is) Lyfjasamsetningar sem innihalda lamivúdín og zídóvúdín
DE69820498D1 (de) Fungizide Mischung, enthaltend ein N-Acetonylbenzamid und Fluazinam
EE200000459A (et) Farmatseutilised kompositsioonid
HK1034188A (en) Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application